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A B ST R AC T  
 
Aim: To compare the parameters showing the platelet volume index in unstable angina pectoris 
(USAP), non-ST elevation myocardial infarction (non-STEMI) and ST elevation myocardial 
infarction (STEMI).  
Methods: The platelet volume indices of 94 USAP, 161 non-STEMI and 86 STEMI cases with a 
total of 341 patients (245 men, 96 women) were compared. The patients between March 2015 and 
October 2018 who admitted to Bolu Abant Izzet Baysal University Hospital with the diagnosis of 
acute coronary syndrome were compared using platelet distribution width (PDW), PDW to platelet 
ratio (PPR), mean platelet volume (MPV), MPV to platelet ratio (MPR).  
Results: No significant difference was found between the 3 groups in terms of PDW (p = 0.26), PPR 
(p = 0.87), MPV (p = 0.41) and MPR (p = 0.78) values. 
Conclusion: In our study, there was no statistically significant difference between the types of acute 
coronary syndrome and platelet volume indices. 
Keywords: Acute coronary syndromes, mean platelet volume, platelet distribution width, platelet 
volume indices. 
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Introduction 
Coronary artery disease is one of the most 
important health problems in both developed 
and developing countries [1]. Coronary artery 
disease may be in a wide range of stable angina 
pectoris and acute coronary syndrome 
including USAP (unstable angina pectoris), 
non-STEMI (non-ST elevation myocardial 
infarction) and STEMI (ST elevation 
myocardial infarction) and their prognosis and 
course vary widely [2]. Acute coronary 
syndromes are an important cause of 
hospitalization, mortality and morbidity 
worldwide [3]. Destruction and rupture of a 
stable plaque is also a stimulant for 
thrombogenesis and triggers a loss of function 
in the myocardial area of the coronary artery, 
whose flow is impaired in the acute coronary 
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syndrome, as well as the loss of cell death, 
ischemia-induced arrhythmias, and sudden 
cardiac death [4]. The importance and place of 
platelets and other hematological parameters in 
both acute and stable coronary artery diseases 
have been shown in many studies [5]. When 
the relationship between the activity and size 
of platelets is examined, it is known that 
thrombogenic activity of platelets increases in 
their size to the increase of thrombogenic 
granules on the platelets and of the receptors 
on the surface [6]. PDW (platelet distribution 
width), PPR (PDW to platelet ratio), MPV 
(mean platelet volume), MPR (MPV to platelet 
ratio) values are parameters that show the size 
and activity of platelets [7,8,9]. These 
parameters, which are indirect indicators of 
platelet activation, have been studied in a wide 
variety of disease groups such as cancer, 
inflammatory diseases, rheumatologic 
diseases, hypertension, diabetes, dyslipidemia 
and obesity and the effects of them on the 
diagnosis, follow-up and prognosis of diseases 
were shown in the literature [10,11]. 
The aim of our study is to compare the platelet 
volume indices using PDW, PPR, MPV and 




Between March 2015 and October 2018, a total 
of 341 patients (245 men, 96 women) with 94 
USAP, 116 non-STEMI and 86 STEMI who 
admitted to our hospital with the diagnosis of 
acute coronary syndrome were evaluated with 
coronary angiography results and hemogram 
parameters. 
Age, gender, drugs, smoking, hypertension, 
hyperlipidemia, diabetes and family history, 
height and weight data were recorded in all 
patients. Hypertension diagnosed in patients 
with systolic blood pressure > 140 mmHg 
and/or diastolic blood pressure > 90 mmHg or 
presently receiving anti-hypertensive 
treatment. Diabetes was defined as fasting 
blood glucose > 126 mg/dl or related drug 
intake. Hyperlipidemia was defined as total 
cholesterol > 200 mg/dl or triglyceride > 150 
mg/dl. 
Patients with acute chest pain and persistent 
(>20 min) ST-segment elevation were defined 
as STEMI. Patients with acute chest pain but 
no persistent ST-segment elevation (transient 
ST-segment elevation, persistent or transient 
ST-segment depression, T-wave inversion, flat 
T waves or pseudo-normalization of T waves 
or normal ECG) and a clue for myocardial 
necrosis defined as NSTEMI. Unstable angina 
was defined as myocardial ischemia at rest or 
minimal exertion in the absence of 
cardiomyocyte necrosis [12]. 
The criteria for ST segment elevation were 
taken as follows: 1) At least 1 mm ST segment 
elevation in at least two successive leads, 2) 
2.5 mm in men under 40 years of age, 2 mm in 
men over 40 years and 1.5 mm ST segment 
elevation in women in V2 and V3, 3) 0.5 mm 
ST segment elevation in V7-V9 (at least 2 
consecutive lines), 4) 0.5 mm ST segment 
elevation in V3R and V4R (1 mm in men under 
40). 
Coronary angiography was performed by 
femoral or radial route using Seldinger 
technique. Coronary angiograms were 
evaluated by at least two cardiologists who 
were experienced and blinded to the 
independent study. 
Venous blood samples were taken within the 
first 6 h of admission to hospital. Glucose, 
creatinine and lipid profiles were determined 
by standard methods. MPV and PDW values 
were studied in tri-potassium EDTA 
(Ethylenediaminetetraacetic acid) tubes. The 
PPR was calculated by dividing the PDW 
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value by the number of platelets and MPR was 
calculated by dividing the MPV value by the 
number of platelets. Patients who were 
diagnosed with acute coronary syndrome in the 
last 6 months, patients with coronary bypass 
history, decompensated heart failure, atrial 
fibrillation, cardiomyopathy or congenital 
heart disease, inflammatory disease, renal or 
hepatic failure, cancer, septicemia, pregnancy 
and thrombocytopenia were excluded from the 
study. The study was approved by the Local 
Ethics Committee of Bolu Abant Izzet Baysal 































Analyses were carried out using SPSS 16.0 
Statistical Package Program for Windows 
(SPSS Inc, Chicago, Illinois, USA).  
Quantitative variables are expressed as mean± 
standard deviation (SD), and qualitative 
variables as numbers and percentages. 
Differences between independent groups was 
assessed by Student t-test for normally 
distributed quantitative variables and Mann-
Whitney’s U-test for variables without normal 
distribution and Chi-square test for qualitative 
variables. All results were considered 
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Baseline patient demographics, including age, 
sex and clinical risk factors, were compared 
between the groups. While demographic 
factors of age, gender, smoking, family history 
and presence of diabetes were not statistically 
significant among the 3 groups, body mass 
index was the lowest in the USAP group and 
the highest in the STEMI group (p=0.004). 
The presence of hypertension was the lowest in 
the STEMI group and the highest in non-
STEMI group (p=0.002). Previous 
medications were also comparable between the 






























While the use of acetylsalicylate, clopidogrel, 
statin, calcium channel blocker and ACE 
(angiotensin-converting enzyme) inhibitor 
were not significantly different between 
groups; ARB (angiotensin receptor blocker) 
and beta-blockers were found to be the lowest 
in the STEMI group and the highest in the non-
STEMI group (p=0.008 and p=0.001) (Table 
1). 
When blood parameters of patients were 
examined, no significant difference was found 
between creatinine, LDL-cholesterol, HDL-
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hematocrit, hemoglobin and platelet counts 
while plasma glucose levels were highest in the 
USAP group; lowest in the STEMI group (p = 
0.02). There was no statistically significant 
difference between the three groups in terms of 
platelet function tests which formed the aim of 
our study, PDW (p=0.26), PPR (p=0.87), 
MPV (p=0.41) and MPR (p=0.78) (Table 2). 
 
Discussion 
In this study, platelet volume indices PDW, 
PPR, MPV and MPR values were not 
significantly different among the patients with 
acute coronary syndrome. Atherosclerosis 
causing coronary artery disease (CAD) is a 
chronic process. After a silent period, a stable 
or unstable clinical picture may occur. Acute 
coronary syndrome (ACS) is a wide spectrum 
of exacerbation periods, including USAP, non-
STEMI and STEMI. Inflammation and platelet 
activation are the cornerstones of both 
atherosclerosis and acute coronary syndromes. 
Platelets are important triggers in the 
atherothrombotic process with their direct 
inflammatory mediators as well as their direct 
effects on the inflammatory pathway [13]. 
Activated platelets initiate the free arachidonic 
acid pathway; prostaglandins produced in the 
process starting with this pathway, especially 
thromboxane A2 is the most potent 
vasoconstrictor and platelet activating 
substrate [14]. Large platelets are more 
enzymatic and metabolically more active due 
to the higher content of pro-aggregate 
mediators and more surface proteins (p-
selectin, Glycoprotein -IIb/IIIa) [15,16]. The 
two most well-known parameters showing the 
platelet size are MPV and PDW, and these two 
values have been used in the literature for 
many times [7,19-30]. PDW is more specific in 
demonstrating activation; unlike MPV, it does 
not increase with simple platelet swelling [17]. 
An example might be the correlation between 
increased PDW and MPV with shortened 
bleeding time [18]. In addition to studying the 
prognostic significance of these markers in a 
wide variety of patient groups, patients with 
acute coronary syndrome were compared with 
stable coronary artery disease and non-cardiac 
patients [2]. The comparison between the 3 
groups was not found in the existing literature 
and such a comparison of these values 
especially in the Turkish population constitutes 
a first study. 
In the literature, platelet volume, PDW and P-
LCR (platelet larger cell ratio) values were 
significantly higher in USAP and acute MI 
patients than in stable CAD and control group 
[19]. While these values were used for 
prognosis as well, PDW value was determined 
as a predictor in the patients who had 
saphenous vein occlusion [20]. In another 
study, STEMI patients were compared with the 
control group and as a result, PDW and MPV 
values were found to be significantly high and 
were associated with STEMI severity [7]. 
Following the literature there are studies in 
parallel with the results of our study, in which 
no significant relationship was observed. For 
example, in 1300 patients who underwent 
percutaneous coronary intervention, in the 
study that investigated the relationship 
between peri-procedural MI and PDW, patients 
were examined in 3 groups according to PDW 
value and it was concluded that the increase in 
PDW did not increase the risk of peri-
procedural MI [21]. In another study, 2330 
patients who underwent coronary angiography 
were divided into 3 groups. There was no 
significant relationship between CAD grade 
and carotid IMT (intima-media thickness), 
MPV and PDW [18]. Similar findings were 
also found in the studies of Tavil et al and 
Halbmayer et al [22-24]. In the literature, the 
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relation of MPR and PPR ratios of platelet 
volume indices with prognosis in various 
cancer types have been studied [25]. The 
correlation with the severity of coronary artery 
disease in patients with non-STEMI [26] and 
the relationship with disease severity in 
pediatric intensive care unit (PICU) [27] have 
been studied previously. However, in our 
study, these values were compared in 3 types 
of acute coronary syndromes. 
In our study, we examined patients in 3 groups 
under the title of acute coronary syndrome and 
compared them with platelet volume index 
parameters, however we did not find any 
significant difference. Although these 3 
clinical manifestations may present with 
different clinical and severity, the underlying 
pathophysiological events may overlap in a 
common pathway. In addition, circulating 
platelets have a life span of about 10 days [28]. 
Since, the blood samples were taken from the 
patients who were in the first 6 h of 
hospitalization, our calculation included the 
90% of the platelets which are in fact 
independent of the acute coronary syndrome 
but already in the circulation at the time of 
measurement. Thus, this may explain the 
statistical insignificance between the groups. 
Although previous studies have shown that 
these values change with blood uptake in 
supine or sitting position [29], patients’ 
positions during blood collection could not be 
standardized due to the retrospective design of 
our study. This deficiency may have affected 
statistical values. The fact that the study was 
conducted only in the Turkish population may 
prevent us to generalize the values that have 
been shown to be influenced by ethnic factors 
[30]. Single-center and the limited number of 
patients might be considered as the other 
limitations in our study. 
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